Researchers discovered a possible weakness in the deadly hospital superbug C. auris that could lead to new treatments for the ...

The potentially deadly fungus has infected over 7,000 people in the U.S. so far this year, and is resistant to many drugs.

Patients taking Tibsovo to treat MDS or AML may want to discuss the appropriate medications to treat and prevent infections, an expert said. Tibsovo (ivosidenib), which is used to treat patients with ...

A deadly hospital fungus that resists nearly every antifungal drug may have an unexpected weakness. Researchers discovered ...

A deadly, drug-resistant fungus is extending its tendrils around the world. Research out this month finds that the public ...

A new study involving the Medical University of Vienna shows how the multi-resistant fungus Candida auris utilizes carbon ...

A Kips Bay biotech company backed by life sciences investment firm Deerfield raised $81 million in a Series B funding round this week to continue developing a new antifungal drug. Elion Therapeutics, ...

The Centers for Disease Control and Prevention is calling an emerging fungus an “urgent threat” after a new study showed it has been spreading at an “alarming rate” throughout health care facilities.

Fungi are everywhere, and in many cases, a fungal infection can be eliminated by a person's immune system. But fungal infections can also send long hyphae into the body that are extremely difficult to ...

This is read by an automated voice. Please report any issues or inconsistencies here. Patients usually walk in assuming the worst. They see patchy, discolored skin spreading across their chest or back ...

The CDC's fungal meningitis risk period of 42 days ends as new cases surface. Nov. 7, 2012— -- The 42-day risk period for contracting fungal meningitis from tainted steroid injections ended on ...